Correlation between the expression of cyclin A protein and p53 activity in oral squamous cell carcinomas

Cytobios

Volumn 106, Issue 412, 2001, Pages 87-99

  Chen, Qianming ^a,b,c   Zhou, Hongyu ^a,b   Guo, Wei ^a   Samaranayake, Lakshman P ^a   Zhou, Min ^a,b   Li, Binzi ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b SICHUAN UNIVERSITY   (China)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cyclin A; p53 proteins; Premalignant lesions; Squamous cell carcinomas

Indexed keywords

CYCLIN A; PROTEIN P53;

ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE; METABOLISM; MOUTH TUMOR; MUTATION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PILOT STUDY; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; CYCLIN A; G1 PHASE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; MOUTH NEOPLASMS; MUTATION; PILOT PROJECTS; S PHASE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0035237931     PISSN: 00114529     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. AXELL T., Pindborg J. J., Smith C. J. and Waal Van Der I. 1996. Oral white lesions with special reference to precancerous and tobacco-related lesions: conclusions of an international symposium held in Uppsala, Sweden, May 18-21, 1994. J. oral Path. Med. 25 49-54.
2. BAKER S. J., Preisinger A. S., Jessup J. M., Paraskeva C., Markowitz S., Wilison J. K., Hamilton S. and Vogelstein B. 1990. p53 gene mutations occur in combination with 17p alleic deletions as late events in colorectal tumorigenesis. Cancer Res. 50 7717-22.
3. BJARNASON G. A., Jordan R. C. and Sothern R. B. 1999. Circadian variation in the expression of cell-cycle proteins in human oral epithelium. Am. J. Path. 154 613-22.
4. CHEN Q., Li B., Fu J. and Yang G. 1996. A study on the mutation of p53 gene by polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP) in oral carcinogenesis. Chinese J. Stomatol. 31 337-40.
5. CHEN Q., Luo G., Li B. and Samaranayake L. P. 1999a. Expression of p16 and cdk4 in oral premalignant lesions and oral squamous cell carcinomas: a semi-quantitative immunohistochemical study. J. oral Path. Med. 28 158-64.
6. CHEN Q., Samaranayake, L. P., Zhen X., Luo G., Nie M. and Li B. 1999b. Up-regulation of Fas ligand and down-regulation of Fas expression in oral carcinogenesis. Oral Oncol. 35 548-53.
7. 1-S phase protein kinase. Science 257 1958-61.
8. DUTTA A., Chandra R., Leiter L. and Lester S. 1995. Cyclins as markers of tumor proliferation: immunocytochemical studies in breast cancer. Proc. natn. Acad. Sci. U.S.A. 92 5386-90.
9. 1 arrest and apoptosis. Cancer Res. 54 1169-74.
10. GIRARD F., Strausfield U., Fernandez A. and Lamb N. 1991. Cyclin A is required for the onset of DNA replication in mammalian fibroblasts. Cell 67 169-79.
11. GOODGER N. M., Gannon J., Hunt T. and Morgan P. R. 1997. Cell cycle regulatory proteins - an overview with relevance to oral cancer. Oral Oncol. J. 33 61-73.
12. HENGLEIN B., Chenivesse X., Wang J., Eick D. and Brechot C. 1994. Structure and cell cycle-regulated transcription of the human cyclin A gene. Proc. natn. Acad. Sci. U.S.A. 91 5490-4.
13. HOLLSTEIN M., Sidransky D., Vogelsteins B. and Harris C. C. 1991. P53 mutations in human cancers. Science 253 49-53.
14. INHARA S. and Kitano Y. 1994. Immunohistochemical detection of cyclin D and cyclin A in human hyperproliferative epidermis. Arch. Dermatol. Res. 286 504-6.
15. JIN Y. M., Yim H. and Shim C. 1997. Cyclin E expression in benign and malignant epithelial neoplasms of the gall bladder. Yonsei Med. J. 38 301-6.
16. JORDAN R. C., Bradley C. and Slingerland J. 1998. Reduced levels of the cell-cycle inhibitor p27Kip1 in epithelial dysplasia and carcinoma of the oral cavity. Am. J. Path. 152 585-90.
17. 1 phase of the human cell cycle. Science 257 1689-94.
18. KUERBITZ S. J., Ppunkett B. S., Walsh W. V. and Kastan M. B. 1992. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. natn. Acad. Sci. U.S.A. 89 7491-5.
19. KUSHNER J., Bradley G., Young B. and Jordan R. C. R. 1999. Aberrant expression of cyclin A and cyclin B1 proteins in oral carcinoma. J. oral Path. Med. 28 77-81.
20. LIU T. J., El-Naggar A. D., McDonnell T. J., Steck K. D., Wang M., Taylor D. L. and Clayman G. L. 1995. Apoptosis induction mediated by wild-type p53 adenoviral gene transfer in squamous cell carcinoma of the head and neck. Cancer Res. 55 3117-22.
21. MARTIN H. M., Filipe M. I., Morris R. W., Lane D. P and Silvestre F. 1992. p53 expression and prognosis in gastric carcinoma. Int. J. Cancer 50 859-62.
22. MASHAL R. D., Lester R. S., Corless C., Richie J. R, Chandra R., Propert K. J. and Dutta A. 1996. Expression of cell cycle-regulated proteins in prostate cancer. Cancer Res. 56 4159-63.
23. MATSUDA H., Konishi N., Hiasa Y., Hayashi I., Tsuzuki T., Tao M., Kitahori Y., Yoshioka N., Kirita T. and Sugimura M. 1996. Alterations of p16/CDKN2, p53 and ras genes in oral squamous cell carcinomas and premalignant lesions. J. oral Path. Med. 25 232-8.
24. PINDBORG J. J., Reichart P. A., Smith C. J. and Waal Van Der I. 1997. Histological typing of cancer and precancer of the oral mucosa. pp 11-13. Second editn. World Health Organization. Springer.
25. PINES J. and Hunter T. 1991. Human cyclins A and B1 are differentially located in the cell and undergo cell cycle-dependent nuclear transport. J. cell Biol. 15 1-17.
26. ROBERTS J. 1993. Turning DNA replication on and off. Curr. Opin. Cell Biol. 5 201-6.
27. SHERR C. J. 1996. Cancer cell cycles. Science 274 1672-7.
28. VOLM M., Koomagi R., Mattern J. and Stammler G. 1997. Cyclin A is associated with an unfavourable outcome in patients with non-small-cell lung carcinomas. Brit. J. Cancer 75 1774-8.